Abstract:Abstract Background Blastocystis is a single-cell gut protist, presumably an indicator of gut health. We aimed to assess its occurrence and subtypes in a longitudinal set of faecal samples from recently diagnosed paediatric patients with Crohn's disease (CD) and compare it to similar longitudinal collections from children having other chronic immunopathological diseases without gut pathology (type 1 diabetes, T1D, and juvenile idiopathic arthritis, JIA), as well as to control subjects. Methods At a single tertiary centre, 626 samples were collected from 156 subjects: 40 with CD (mean age 12.5 years), 57 with T1D, 10 with JIA and 49 healthy. Specific real-time PCR detected and quantified Blastocytis, whereas massively parallel amplicon sequencing showed its subtype. The relationship between Blastocystis and the bacterial community was assessed by 16S rDNA amplicon profiling. Results Blastocystis was detected in 4.0% (9/223) stool samples in CD, six of them being of a very high quantity and originating from a single patient in long-term remission with a less common CD phenotype (L2, colonic, according to Paris classification). Subject-wise positivity of Blastocystis in CD (3/40, 7.5%) was significantly lower than in either T1D (21/57, 37%), JIA (2/10, 20%), or in healthy children (14/49, 29%). There was no notable difference in the subtype repertoires among diagnoses. The faecal bacteriome had higher alpha diversity in Blastocystis-positive samples. The Blastocystis-positive bacteriomes had slightly yet significantly (p<0.001) different overall community composition across all diagnoses (Figure 1), which was also reflected by the suggestive differential abundance of several taxa (e.g. Ruminococcaceae and Prevotellaceae increased, Bacteroidaceae and Rikenellaceae decreased). Conclusion We performed a large molecular survey on Blastocystis in longitudinal samples of three different paediatric diagnoses and healthy subjects. We document an unusual long-term carriage of very high loads of Blastocystis in a patient with colonic CD phenotype in clinical remission. Otherwise, however, Blastocystis is very rare among paediatric patients with CD, in contrast to two other chronic immunopathologic childhood diagnoses (T1D, JIA). Further longitudinal observation will show whether Blastocystis might return in patients with well-controlled CD upon ameliorating their bacteriome composition. Institutional Grants/Research Supports Supported by Ministry of Education, Youth and Sports of the Czech Republic, programme INTER-EXCELLENCE II, project LUC23165.

Effects of Lactiplantibacillus plantarum and Lacticaseibacillus paracasei supplementation on the single-cell fecal parasitome in children with celiac disease autoimmunity: a randomized, double-blind placebo-controlled clinical trial

Effects of Probiotic Bacteria Lactobacillaceae on the Gut Microbiota in Children With Celiac Disease Autoimmunity: A Placebo-Controlled and Randomized Clinical Trial

Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease

Effect of probiotic supplementation on total lactobacilli, bifidobacteria and short chain fatty acids in 2–5-year-old children

Effect of Bifidobacterium infantis NLS super strain in symptomatic coeliac disease patients on long-term gluten-free diet - an exploratory study

The Impact of Helicobacter Pylori Infection, Eradication Therapy and Probiotic Supplementation on Gut Microenvironment Homeostasis: an Open-Label, Randomized Clinical Trial

The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study

Decrease in lactobacilli in the intestinal microbiota of celiac children with a gluten-free diet, and selection of potentially probiotic strains

Effect of Lactobacillaceae Probiotics on Colonic Microbiota and Metabolite Production in Cystic Fibrosis: A Comparative In Vitro Study

The Effect of Oligofructose-Enriched Inulin on Faecal Bacterial Counts and Microbiota-Associated Characteristics in Celiac Disease Children Following a Gluten-Free Diet: Results of a Randomized, Placebo-Controlled Trial

Enteric parasitic infection disturbs bacterial structure in Mexican children with autoantibodies for type 1 diabetes and/or celiac disease

Influence of Lactobacillus F19 on Intestinal Microflora in Children and Elderly Persons and Impact on Helicobacter pylori Infections

Effect of Lacticaseibacillus Paracasei N1115 on Immunomodulatory and Gut Microbial Composition in Young Children: A Randomized, Placebo-Controlled Study.

Effect of Bifidobacterium breve on the Intestinal Microbiota of Coeliac Children on a Gluten Free Diet: A Pilot Study

Probiotics and the Microbiome in Celiac Disease: A Randomised Controlled Trial

Impact of intestinal parasites on microbiota and cobalamin gene sequences: a pilot study

Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, and Intestinal Microbiota in Healthy Adults: A Randomised, Parallel, Double-Blind, Placebo-Controlled Pilot Study

Probiotics in primary prevention of allergic disease--follow-up at 8-9 years of age

P1215 Blastocystis is very rare in faeces of children with Crohn’s disease: quantity, subtyping and association with the faecal bacteriome

Preliminary study on the potential impact of probiotic combination therapy on Helicobacter pylori infection in children using 16S gene sequencing and untargeted metabolomics approach

Safety and Tolerance of Lacticaseibacillus Paracasei N1115 in Caesarean-Born Young Children: a Randomised, Placebo-Controlled Trial.